In line with these findings, a higher quantity of active caspase-1 was observed in brain lysates from AD and moderate cognitive-impairment (MCI) patients compared to healthy subjects, indicating chronic inflammasome activity in these pathologies [61,70]. Here, CASP1 is linked to Alzheimer disease.